Effect of Anti-interleukin 5 (IL5) Therapy on Sputum Cells and Cytokines
Status:
Completed
Trial end date:
2019-03-01
Target enrollment:
Participant gender:
Summary
22 asthmatics, in which mepolizumab was to be started, gave permission for inclusion and were
followed up prospectively. Clinical and lung functional data, sputum analyses and cytokine
measurements were analyzed.